#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4419015	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R40 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
2.	ALA4419032	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R40 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of cohumulone-induced intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2		cell-based format	Patent Bioactivity Data
3.	ALA4419221	F	Agonist activity at human TAS2R40 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
4.	ALA4419246	F	Agonist activity at human TAS2R40 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level at 20 mM by Calcium-3 dye based fluorescence assay relative to control	Homo sapiens	3		cell-based format	Patent Bioactivity Data
5.	ALA4421752	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R40 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
6.	ALA4421785	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R40 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of cohumulone-induced intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2		cell-based format	Patent Bioactivity Data